The Relationship between Serum Bilirubin and Inflammatory Bowel Disease

Table 2

Serum total bilirubin (sTB) levels in patients with IBD.

(a)

Groups	Control ()		CD ()		UC ()
	Serum bilirubin (μmol/L)		Serum bilirubin (μmol/L)		Serum bilirubin (μmol/L)
Sex
Male	13.2 (9.9-16.2) ()	0.009	8.5 (6.2-11.3) ()	0.027	9.5 (7.1-13.7) ()	0.339
Female	11.2 (8.9-14.4) ()		7.1 (5.3-9.4) ()		9.6 (6.6-12.8) ()
Age group (yr)
<30	11.1 (8.7-13.6) ()	0.266	7.8 (5.4-10.7) ()	0.500	7.3 (5.9-9.7) ()	0.008
30–50	12.4 (9.6-15.2) ()		8.0 (5.9-11.7) ()		9.6 (7.8-14.2) ()
>50	12.3 (10.1-15.9) ()		7.6 (7.1-9.3) ()		10.8 (7.1-13.5) ()

(b)

Groups	Control ()	CD ()	UC ()
	Serum bilirubin (μmol/L)	Serum bilirubin (μmol/L)	Serum bilirubin (μmol/L)
Sex
Male	13.2 (9.9-16.2) ()	8.5 (6.2-11.3) ()	9.5 (7.1-13.7) ()	0.001
Female	11.2 (8.9-14.4) ()	7.1 (5.3-9.4) ()	9.6 (6.6-12.8) ()	0.001
Age group (yr)
<30	11.1 (8.7-13.6) ()	7.8 (5.4-10.7) ()	7.3 (5.9-9.7) ()	0.002
30–50	12.4 (9.6-15.2) ()	8.0 (5.9-11.7) ()	9.6 (7.8-14.2) ()	0.001
>50	12.3 (10.1-15.9) ()	7.6 (7.1-9.3) ()	10.8 (7.1-13.5) ()	0.001